Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 262-271

  Long, Mark D ^a   Thorne, James L ^b   Russell, James ^a   Battaglia, Sebastiano ^a   Singh, Prashant K ^a   Sucheston Campbell, Lara E ^a   Campbell, Moray J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

22 HYDROXYCHOLESTEROL; CALCITRIOL; CELL NUCLEUS RECEPTOR; CHENODEOXYCHOLIC ACID; ICOSATETRAENOIC ACID; MICRORNA;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL FUNCTION; CELL PROLIFERATION; COMPUTER MODEL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE TUMOR; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; PROSTATE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84893359797     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt334     Document Type: Article

References (59)

1. Battaglia,S. et al. (2010) Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis, 31, 1650-1660.
2. Baranowski,M. (2008) Biological role of liver X receptors. J. Physiol. Pharmacol., 59 (suppl. 7), 31-55.
3. Abedin,S.A. et al. (2009) Elevated NCOR1 disrupts a network of dietarysensing nuclear receptors in bladder cancer cells. Carcinogenesis, 30, 449-456.
4. Kacevska,M. et al. (2011) Extrahepatic cancer suppresses nuclear receptorregulated drug metabolism. Clin. Cancer Res., 17, 3170-3180.
5. Kaeding,J. et al. (2008) Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells. Biochem. J., 410, 245-253.
6. Zhang,Z. et al. (2004) Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Res., 14, 580-590.
7. Lohnes,D. et al. (1995) Developmental roles of the retinoic acid receptors. J. Steroid Biochem. Mol. Biol., 53, 475-486.
8. Pommier,A.J. et al. (2013) Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice. PLoS Genet., 9, e1003483.
9. Khanim,F.L. et al. (2004) Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene, 23, 6712-6725.
10. Elstner,E. et al. (1999) Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate, 40, 141-149.
11. Campbell,M.J. et al. (1998) Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog. Endocrinology, 139, 1972-1980.
12. Campbell,M.J. et al. (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol., 19, 15-27.
13. Berquin,I.M. et al. (2007) Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J. Clin. Invest., 117, 1866-1875.
14. Augustsson,K. et al. (2003) A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol. Biomarkers Prev., 12, 64-67.
15. Terry,P. et al. (2001) Fatty fish consumption and risk of prostate cancer. Lancet, 357, 1764-1766.
16. Holick,M.F. (2008) Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin. J. Am. Soc. Nephrol., 3, 1548-1554.
17. Bernstein,H. et al. (2009) Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroenterol., 15, 3329-3340.
18. Hu,J. et al. (2011) Dietary cholesterol intake and cancer. Ann. Oncol., 23, 491-500.
19. Perissi,V. et al. (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol., 6, 542-554.
20. Boergesen,M. et al. (2012) Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor a in mouse liver reveals extensive sharing of binding sites. Mol. Cell. Biol., 32, 852-867.
21. Campbell,M.J. et al. (1999) Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid. Br. J. Cancer, 79, 101-107.
22. Sobel,R.E. et al. (2005) Cell lines used in prostate cancer research: a compendium of old and new lines-part 2. J. Urol., 173, 360-372.
23. Bello,D. et al. (1997) Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis, 18, 1215-1223.
24. Livak,K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
25. Lal,A. et al. (1999) A public database for gene expression in human cancers. Cancer Res., 59, 5403-5407.
26. Cerami,E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
27. Taylor,B.S. et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell, 18, 11-22.
28. Uhlén,M. et al. (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteomics, 4, 1920-1932.
29. Chawla,A. et al. (2001) A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell, 7, 161-171.
30. Galvez,A.F. et al. (2011) Differential expression of thrombospondin (THBS1) in tumorigenic and nontumorigenic prostate epithelial cells in response to a chromatin-binding soy peptide. Nutr. Cancer, 63, 623-636.
31. Dweep,H. et al. (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform., 44, 839-847.
32. Hudson,R.S. et al. (2013) MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene, 32, 4139-4147.
33. Li,X. et al. (2012) Suppression of CX43 expression by miR-20a in the progression of human prostate cancer. Cancer Biol. Ther., 13, 890-898.
34. Nguyen,H.C. et al. (2013) Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate, 73, 346-354.
35. Kerr,J.F. et al. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257.
36. Yu,J. et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell, 17, 443-454.
37. Bachmann,I.M. et al. (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol., 24, 268-273.
38. Wang,Q. et al. (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell, 138, 245-256.
39. Baker,A.R. et al. (1988) Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl Acad. Sci. USA, 85, 3294-3298.
40. Yegnasubramanian,S. et al. (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res., 64, 1975-1986.
41. Asatiani,E. et al. (2005) Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res., 65, 1164-1173.
42. Mahapatra,S. et al. (2012) Global methylation profiling for risk prediction of prostate cancer. Clin. Cancer Res., 18, 2882-2895.
43. Kim,I. et al. (2007) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis, 28, 940-946.
44. Knisely,A.S. et al. (2006) Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology, 44, 478-486.
45. Yang,M. et al. (2011) SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J. Clin. Oncol., 29, 2565-2573.
46. Grisanzio,C. et al. (2012) Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc. Natl Acad. Sci. USA, 109, 11252-11257.
47. Park,J.Y. et al. (2007) Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor. Cancer Detect. Prev., 31, 359-365.
48. Saylor,P.J. et al. (2012) Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer. Clin. Cancer Res., 18, 3677-3685.
49. Baptissart,M. et al. (2013) Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling? Cell. Mol. Life Sci. [Epub ahead of print] (PMID:23784309).
50. Houten,S.M. et al. (2006) Endocrine functions of bile acids. EMBO J., 25, 1419-1425.
51. Xie,W. et al. (2001) An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl Acad. Sci. USA, 98, 3375-3380.
52. Makishima,M. et al. (2002) Vitamin D receptor as an intestinal bile acid sensor. Science, 296, 1313-1316.
53. El Roz,A. et al. (2012) LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer Res., 32, 3007-3013.
54. Lee,J.H. et al. (2008) Androgen deprivation by activating the liver X receptor. Endocrinology, 149, 3778-3788.
55. Anderson,S.P. et al. (2004) Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol. Pharmacol., 66, 1440-1452.
56. Hu,J. et al.; Canadian Cancer Registries Epidemiology Research Group. (2012) Dietary cholesterol intake and cancer. Ann. Oncol., 23, 491-500.
57. Murtola,T.J. et al. (2012) The importance of LDL and cholesterol metabolism for prostate epithelial cell growth. PLoS One, 7, e39445.
58. Battaglia,S. et al. (2010) Transcription factor co-repressors in cancer biology: roles and targeting. Int. J. Cancer, 126, 2511-2519.
59. Thorne,J.L. et al. (2011) Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in nonmalignant prostate cells. Nucleic Acids Res., 39, 2045-2056.